Search by Drug Name or NDC
NDC 68180-0801-36 Lapatinib 250 mg/1 Details
Lapatinib 250 mg/1
Lapatinib is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is LAPATINIB DITOSYLATE.
MedlinePlus Drug Summary
Lapatinib is used with capecitabine (Xeloda) to treat a certain type of advanced breast cancer in people who have already been treated with other chemotherapy medications. Lapatinib is also used with letrozole (Femara) to treat a certain type of breast cancer in postmenopausal women (women who have experienced a change of life; end of menstrual periods) that has spread to other parts of the body. Lapatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells.
Related Packages: 68180-0801-36Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lapatinib
Product Information
| NDC | 68180-0801 |
|---|---|
| Product ID | 68180-801_83e11e1b-056e-4c28-b2d3-825ff1b804e1 |
| Associated GPIs | 21533026100320 |
| GCN Sequence Number | 062364 |
| GCN Sequence Number Description | lapatinib ditosylate TABLET 250 MG ORAL |
| HIC3 | V1Q |
| HIC3 Description | ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS |
| GCN | 98140 |
| HICL Sequence Number | 034541 |
| HICL Sequence Number Description | LAPATINIB DITOSYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Lapatinib |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | lapatinib |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | LAPATINIB DITOSYLATE |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Pharmaceutical Class | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203007 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68180-0801-36 (68180080136)
| NDC Package Code | 68180-801-36 |
|---|---|
| Billing NDC | 68180080136 |
| Package | 150 TABLET in 1 BOTTLE (68180-801-36) |
| Marketing Start Date | 2020-09-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |